CSF2 and breast cancer: In particular, we found that the BC treatment decreased the levels of nine biological mediators out of the 27 assayed, namely IL-6, IL-8, IL-9, IL-12, FGF-bb, GM-CSF, IP-10, MCAF, and VEGF.